MICALLEF JACOB VINCENT (Chief Scientific Officer) purchased 24.1% of their position (29K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $50.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/30/2022ACC: 0001477932-22-006505
Officer· Chief Scientific Officer
+29K
Net shares
Net buyer
$50.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
29K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+29K
Price / share
$1.74
Trade value
$50.46K
% of position
24.1%
—
120.23K→149.23K
Total
Net shares
+29K
Net value
$50.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +29K | $1.74 | $50.46K | 24.1% | 120.23K | 149.23K |
| Total | +29K | $50.46K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned22K
Common Stock
IndirectShares owned38.11K
Total
60.11K indirect60.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22K | Indirect |
| Common Stock | 38.11K | Indirect |
| Total | 60.11K | 60.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported